A detailed history of Kynam Capital Management, LP transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 2,356,147 shares of CRBU stock, worth $4.62 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
2,356,147
Previous 1,646,702 43.08%
Holding current value
$4.62 Million
Previous $2.7 Million 70.15%
% of portfolio
0.38%
Previous 0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.56 - $2.73 $1.11 Million - $1.94 Million
709,445 Added 43.08%
2,356,147 $4.59 Million
Q2 2024

Aug 14, 2024

BUY
$1.62 - $5.05 $936,643 - $2.92 Million
578,175 Added 54.11%
1,646,702 $2.7 Million
Q3 2023

Nov 14, 2023

BUY
$4.08 - $8.14 $4.36 Million - $8.7 Million
1,068,527 New
1,068,527 $5.11 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $119M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.